These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 2931285)
21. Tryptaminergic receptors in the bovine pulmonary vasculature: effects of ketanserin. Ogunbiyi PO; Eyre P Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):31-55. PubMed ID: 6328601 [TBL] [Abstract][Full Text] [Related]
22. Comparison of the effects of IVth ventricular administration of some tryptamine analogues with those of 8-OH-DPAT on autonomic outflow in the anaesthetized cat. Shepheard SL; Jordan D; Ramage AG Br J Pharmacol; 1994 Feb; 111(2):616-24. PubMed ID: 8004405 [TBL] [Abstract][Full Text] [Related]
23. Differential actions of serotonin antagonists on two behavioral models of serotonin receptor activation in the rat. Lucki I; Nobler MS; Frazer A J Pharmacol Exp Ther; 1984 Jan; 228(1):133-9. PubMed ID: 6694097 [TBL] [Abstract][Full Text] [Related]
24. Can the 5-HT2/1c agonist DOI cause differential sympatho-excitation in nerves supplying the heart in anaesthetized cats? Ramage AG; Shepheard SL; Jordan D; Koss MC J Auton Nerv Syst; 1993 Jan; 42(1):53-62. PubMed ID: 8436806 [TBL] [Abstract][Full Text] [Related]
25. A comparison of cardiovascular and smooth muscle effects of 5-hydroxytryptamine and 5-carboxamidotryptamine, a selective agonist of 5-HT1 receptors. Saxena PR; Lawang A Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):235-52. PubMed ID: 2933009 [TBL] [Abstract][Full Text] [Related]
26. Effects of serotonin1 and serotonin2 receptor agonists and antagonists on blood pressure, heart rate and sympathetic nerve activity. McCall RB; Patel BN; Harris LT J Pharmacol Exp Ther; 1987 Sep; 242(3):1152-9. PubMed ID: 2958619 [TBL] [Abstract][Full Text] [Related]
27. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats. Lozano-Cuenca J; Muñoz-Islas E; González-Hernández A; Centurión D; Cobos-Puc LE; Sánchez-López A; Pertz HH; Villalón CM Eur J Pharmacol; 2009 Jun; 612(1-3):80-6. PubMed ID: 19356724 [TBL] [Abstract][Full Text] [Related]
29. Allosteric properties of the 5-HT2 receptor system of the rat tail artery. Ritanserin and methysergide are not competitive 5-HT2 receptor antagonists but allosteric modulators. Frenken M; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1987 Apr; 335(4):359-66. PubMed ID: 3110629 [TBL] [Abstract][Full Text] [Related]
30. Central methysergide prevents renal sympathoinhibition and bradycardia during hypotensive hemorrhage. Scrogin KE; Veelken R; Johnson AK Am J Physiol; 1998 Jan; 274(1 Pt 2):H43-51. PubMed ID: 9458850 [TBL] [Abstract][Full Text] [Related]
31. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797 [TBL] [Abstract][Full Text] [Related]
32. Allosteric properties of 5-HT2 receptors in tracheal smooth muscle. Lemoine H; Kaumann AJ Naunyn Schmiedebergs Arch Pharmacol; 1986 Jun; 333(2):91-7. PubMed ID: 2944004 [TBL] [Abstract][Full Text] [Related]
33. Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension. Zabludowski JR; Zoccali C; Isles CG; Murray GD; Robertson JI; Inglis GC; Fraser R; Ball SG Br J Clin Pharmacol; 1984 Mar; 17(3):309-16. PubMed ID: 6712863 [TBL] [Abstract][Full Text] [Related]
34. Reduction in blood pressure, sympathetic nerve discharge and centrally evoked pressor responses by methysergide in anesthetized cats. Antonaccio MJ; Taylor DG Eur J Pharmacol; 1977 Apr; 42(4):331-8. PubMed ID: 852503 [TBL] [Abstract][Full Text] [Related]
35. Studies on the mechanism of action of the hypotensive effect of ketanserin. Marwood JF; Stokes GS Clin Exp Pharmacol Physiol; 1984; 11(2):125-32. PubMed ID: 6086191 [TBL] [Abstract][Full Text] [Related]
36. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb. Jandhyala BS; Kivlighn SD Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343 [TBL] [Abstract][Full Text] [Related]
37. Effect of serotonin receptor blockade on endocrine and cardiovascular responses to head-up tilt in humans. Matzen S; Secher NH; Knigge U; Pawelczyk J; Perko G; Iversen H; Bach FW; Warberg J Acta Physiol Scand; 1993 Oct; 149(2):163-76. PubMed ID: 8266806 [TBL] [Abstract][Full Text] [Related]
38. The influence of 5-hydroxytryptamine agonists and antagonists on identified sympathetic preganglionic neurones in the rat, in vivo. Lewis DI; Coote JH Br J Pharmacol; 1990 Apr; 99(4):667-72. PubMed ID: 2361167 [TBL] [Abstract][Full Text] [Related]
39. Reduction in opioid and non-opioid forms of swim analgesia by 5-HT2 receptor antagonists. Kiefel JM; Paul D; Bodnar RJ Brain Res; 1989 Oct; 500(1-2):231-40. PubMed ID: 2605492 [TBL] [Abstract][Full Text] [Related]
40. Demonstration of alpha-adrenoceptor antagonism by the 5HT2 antagonist, ketanserin (R49945), in sheep. Nelson MA; Coghlan JP; Denton DA; Mills EH; Spence CD; Whitworth JA; Scoggins BA Clin Exp Pharmacol Physiol; 1984; 11(6):597-604. PubMed ID: 6152610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]